Vertraagde tijd
NSE India S.E.
07:13:23 16-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
550
INR
|
+1,15%
|
|
-0,15%
|
+28,14%
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
80.373
|
49.034
|
19.118
|
45.869
|
37.972
|
22.175
|
Bedrijfswaarde
1 |
105.423
|
78.805
|
52.659
|
69.944
|
56.132
|
42.855
|
K/w-verhouding
|
-13,2
x
|
-25,2
x
|
-27,6
x
|
6,68
x
|
-13
x
|
-3,97
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,05
x
|
1,18
x
|
0,67
x
|
1,69
x
|
1,18
x
|
0,84
x
|
Bedrijfswaarde/omzet
|
2,69
x
|
1,9
x
|
1,85
x
|
2,58
x
|
1,74
x
|
1,62
x
|
Bedrijfswaarde/EBITDA
|
-173
x
|
61,6
x
|
169
x
|
-49,1
x
|
24,8
x
|
171
x
|
Bedrijfswaarde/FCF
|
-254
x
|
-25,7
x
|
61,8
x
|
-19,1
x
|
22,8
x
|
-90
x
|
FCF Yield
|
-0,39%
|
-3,89%
|
1,62%
|
-5,24%
|
4,39%
|
-1,11%
|
Price to Book
|
2,86
x
|
1,88
x
|
0,73
x
|
1,39
x
|
1
x
|
0,67
x
|
Aantal aandelen (in duizenden)
|
110.630
|
110.686
|
110.735
|
110.781
|
144.053
|
144.088
|
Referentieprijs
2 |
726,5
|
443,0
|
172,6
|
414,0
|
263,6
|
153,9
|
Datum van publicatie
|
5/08/18
|
17/07/19
|
5/07/20
|
8/07/21
|
20/07/22
|
21/07/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
39.245
|
41.584
|
28.440
|
27.083
|
32.300
|
26.510
|
EBITDA
1 |
-610,7
|
1.279
|
312
|
-1.425
|
2.260
|
250
|
Bedrijfsresultaat (EBIT)
1 |
-2.050
|
-310,9
|
-1.264
|
-3.066
|
510
|
-1.500
|
Operationele Marge
|
-5,22%
|
-0,75%
|
-4,44%
|
-11,32%
|
1,58%
|
-5,66%
|
Resultaat voor belastingen (EBT)
1 |
-6.412
|
-3.003
|
-3.420
|
-5.683
|
-4.110
|
-6.240
|
Nettowinst (verlies)
1 |
-6.083
|
-1.945
|
-692,2
|
6.861
|
-2.440
|
-5.590
|
Nettomarge
|
-15,5%
|
-4,68%
|
-2,43%
|
25,33%
|
-7,55%
|
-21,09%
|
WPA
2 |
-55,01
|
-17,58
|
-6,252
|
61,95
|
-20,24
|
-38,80
|
Free Cash Flow
1 |
-414,7
|
-3.062
|
852,7
|
-3.666
|
2.466
|
-476,2
|
FCF-marge
|
-1,06%
|
-7,36%
|
3%
|
-13,53%
|
7,64%
|
-1,8%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
273,29%
|
-
|
109,13%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
5/08/18
|
17/07/19
|
5/07/20
|
8/07/21
|
20/07/22
|
21/07/23
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
25.050
|
29.772
|
33.541
|
24.075
|
18.160
|
20.680
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-41,02
x
|
23,28
x
|
107,5
x
|
-16,9
x
|
8,035
x
|
82,72
x
|
Free Cash Flow
1 |
-415
|
-3.062
|
853
|
-3.666
|
2.466
|
-476
|
ROE (netto-inkomsten/eigen vermogen)
|
-19,3%
|
-6,99%
|
-4,55%
|
-8,7%
|
-7,01%
|
-15,8%
|
ROA (netto-inkomsten/totale activa)
|
-1,49%
|
-0,24%
|
-0,99%
|
-2,4%
|
0,4%
|
-1,18%
|
Totale activa
1 |
408.009
|
800.865
|
70.210
|
-285.561
|
-613.065
|
474.815
|
Nettoactief per aandeel
2 |
254,0
|
236,0
|
235,0
|
299,0
|
263,0
|
228,0
|
Cashflow per aandeel
2 |
81,10
|
35,90
|
19,80
|
21,00
|
25,70
|
6,250
|
Capex
1 |
3.074
|
2.749
|
1.724
|
805
|
1.180
|
420
|
Capex/omzet
|
7,83%
|
6,61%
|
6,06%
|
2,97%
|
3,65%
|
1,58%
|
Datum van publicatie
|
5/08/18
|
17/07/19
|
5/07/20
|
8/07/21
|
20/07/22
|
21/07/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +28,14% | 1 mld. | | +21,28% | 43,92 mld. | | +24,47% | 23,09 mld. | | +19,22% | 15,35 mld. | | +12,87% | 13,61 mld. | | +44,67% | 12,02 mld. | | -9,92% | 7 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +13,07% | 5,6 mld. |
Generieke geneesmiddelen
|